SHREVEPORT, La., June 22 (UPI) -- Men who consumed compounds in green tea showed a reduction in serum markers predictive of prostate cancer progression, U.S. researchers said.
James A. Cardelli of the Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center-Shreveport, and colleagues conducted an open-label, single-arm, phase II clinical trial to determine the effects of short-term supplementation with green tea's active compounds on serum biomarkers in patients with prostate cancer.